Glasgow University Launches MedTech Innovation Masters Programme (Glasgow, 2026)

Key Points

• University of Glasgow launching MSc in MedTech Innovation in September 2026, developed with InnoScot Health, NHS Greater Glasgow & Clyde, and other partners.
• Programme aims to bridge gap between education and execution for MedTech innovations, positioning Scotland as a global leader.
• Covers full lifecycle: identifying clinical needs, design, development, regulation, implementation, commercialisation, and scaling.
• Includes placements with NHS, government, and MedTech firms; culminates in ‘Innovation Day’ for pitching to stakeholders and funding opportunities.
• Partners: West of Scotland Innovation Hub (WoSIH), NHS Greater Glasgow and Clyde, SafeHaven, National Robotarium, Scottish Ambulance Service, industry leaders like Tile Bio and Lumino.
• Statements from Graham Watson (InnoScot Health Executive Chair) and Katriona Brooksbank (WoSIH Innovation Lead) highlight collaboration and real-world impact.
• InnoScot Health provides regulatory support; recently launched new innovation call for early-stage ideas.

Glasgow (Glasgow Express) April 27, 2026 – A new MSc programme in MedTech Innovation at the University of Glasgow promises to transform healthcare technology development by linking academic research directly to commercial and clinical application.

What is the University of Glasgow’s New MedTech Innovation Masters Programme?

The University of Glasgow has announced the launch of its MSc in MedTech Innovation, set to begin in September 2026. This 12-month course, developed in partnership with InnoScot Health, innovation hubs, industry leaders, and NHS Greater Glasgow & Clyde, targets the full MedTech innovation lifecycle.

As reported across multiple sources covering the announcement, the programme equips participants with skills to identify unmet clinical needs, design solutions, navigate regulations, implement technologies, commercialise products, and scale them globally. It leverages digital, data, and AI technologies to address real-world healthcare challenges.

The University of Glasgow states the MSc positions students “at the intersection of healthcare, technology, and business,” offering placements with NHS bodies, government organisations, and leading MedTech companies. The course ends with an ‘Innovation Day,’ described as a “prestigious showcase” where participants pitch projects to NHS leaders, investors, and industry executives, with access to University funding schemes.

Key partners include the West of Scotland Innovation Hub (WoSIH), NHS Greater Glasgow & Clyde, SafeHaven, the National Robotarium, Scottish Ambulance Service, and industry players such as Scottish SMEs and spinouts like Tile Bio and Lumino.

Why Does InnoScot Health Call This Programme Scotland’s Premier MedTech Initiative?

InnoScot Health, a key partner, describes the programme as “the country’s premier programme of its kind, placing Scotland on the world map by bridging the vital gap between education and execution.”

Executive Chair Graham Watson of InnoScot Health said:

“This is an important step in bringing Scotland’s NHS, industry, and academia closer together while fostering a stronger homegrown pipeline of leading MedTech innovation. The programme represents a significant piece in the puzzle for accelerating promising early-stage ideas into commercial reality through a clearly defined, comprehensive learning pathway. We further believe it could help to spearhead next generation Scottish solutions on a global scale, enhancing accessibility to cutting-edge tech solutions for improved patient outcomes while transforming economic growth.”

Watson further noted Glasgow’s role in Scotland’s MedTech ecosystem, encompassing medical devices, digital health, and in vitro diagnostics. He cited Dr David Brennan, CEO of spinout Aurum Biosciences, who studied Clinical Physics at the University of Glasgow, worked at NHS Greater Glasgow & Clyde, and now leads an ambitious firm targeting medical needs. InnoScot Health provided regulatory support to Aurum and operates under an accredited ISO 13485:2016 framework for medical devices.

InnoScot Health offers regulatory expertise, consultancy, and training to NHS Scotland, academia, and industry. Last month, it launched a new innovation call to inspire early-stage innovators, including students and NHS staff, to address unmet healthcare needs.

How Will the Programme Address Barriers to MedTech Adoption?

The initiative tackles barriers to frontline adoption by integrating practical experience and stakeholder engagement. Participants gain hands-on skills through placements and the Innovation Day, facilitating direct feedback from sector leaders.

Katriona Brooksbank, Innovation Lead at the West of Scotland Innovation Hub (WoSIH), said:

“I am so excited to share the MedTech Innovation Masters programme which covers healthcare innovation opportunity identification and end to end evidence generation as part of a route to get MedTech products safely to market.”

Graham Watson added:

“Academia is often where inspiration begins and early-stage ideas are formed with Glasgow undoubtedly at the heart of Scotland’s high-value, increasingly convergent MedTech ecosystem.”

The University of Glasgow emphasises the programme’s role in revolutionising patient care, stating it offers an opportunity to “be part of the world changing generation that revolutionises patient care using technology.”

Who Are the Key Partners Involved in the MedTech Innovation Masters?

Partners span public, academic, and private sectors:

• West of Scotland Innovation Hub (WoSIH)
• NHS Greater Glasgow and Clyde
• SafeHaven
• The National Robotarium
• Scottish Ambulance Service
• Industry leaders, including national and global firms, Scottish SMEs, and spinouts such as Tile Bio and Lumino

These collaborations ensure the curriculum reflects current industry needs and provides real-world exposure.

What Opportunities Does the Programme Offer Students?

Beyond core learning, the MSc includes placement opportunities for practical experience. The Innovation Day allows pitching to stakeholders, with pathways to University MedTech funding schemes. This structure supports progression from idea to market, addressing regulatory and commercial hurdles early.

The programme builds on Scotland’s strengths in MedTech, with InnoScot Health’s support ensuring compliance and market readiness.

Background of the MedTech Innovation Masters Development

This programme emerges from ongoing efforts to strengthen Scotland’s MedTech sector. Glasgow hosts a converging ecosystem of medical devices, digital health, and diagnostics, supported by institutions like the University of Glasgow and NHS Greater Glasgow & Clyde. InnoScot Health has played a pivotal role, offering regulatory services under ISO 13485:2016 and aiding spinouts like Aurum Biosciences. Recent initiatives, such as InnoScot’s innovation call, target early-stage ideas from students and NHS staff. Partners like WoSIH and the National Robotarium contribute expertise in innovation and technology integration, responding to national ambitions for healthcare advancement through closer NHS-industry-academia ties.

Predictions for Impact on Scottish MedTech Innovators, Students, and Healthcare Providers

This development provides Scottish MedTech innovators, students, and healthcare providers with structured pathways to commercialise ideas, potentially increasing successful product launches and sector investment. Students gain comprehensive skills and networks, improving employability in a growing field. Healthcare providers, via NHS partnerships, access tested innovations faster, aiding frontline adoption. For innovators, regulatory guidance reduces barriers, fostering a stronger pipeline of homegrown solutions that could enhance patient outcomes and contribute to economic growth through job creation and exports.